Explore ongoing and completed research projects from CanRIO members investigating rheumatic immune-related adverse events.
Work in progress! Dr. Shahin Jamal and Dr. Tom Appleton are leading a study on Early Adalimumab Induction for Treatment of Steroid-Dependent Checkpoint Inhibitor Associated Inflammatory Arthritis: A P...
Coming 2024/2025! With support from the Canadian Rheumatology Association (CRA) Guidelines Committee, CanRIO has assembled a working group of rheumatologists, oncologist and patient representative to ...
Currently recruiting! This is an ongoing prospective, multi-centre, Canadian study looking at clinical phenotypes, outcomes and biomarker profiles of adults with rheumatic immune related adverse event...
Are you a physician interested in contributing to CanRIO research? We're always looking for collaborators across Canada.
Learn About Investigator Resources